Gibson, Dunn & Crutcher advised Jade Biosciences on the transaction, and Cooley advised the placement agents; while Goodwin Procter advised Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc....
Jade Biosciences’ Merger with Aerovate Therapeutics
Aerovate Therapeutics’ IPO
Brown Rudnick advised Aerovate Therapeutics Inc. on the deal. Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve...